Chartwell Investment Partners’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-21,377
Closed -$1.17M – 436
2023
Q1
$1.17M Sell
21,377
-12,323
-37% -$720K 0.04% 328
2022
Q4
$2.11M Sell
33,700
-17,774
-35% -$1.18M 0.08% 261
2022
Q3
$3.63M Buy
51,474
+1,802
+4% +$124K 0.15% 209
2022
Q2
$2.81M Buy
49,672
+1,242
+3% +$68.1K 0.11% 245
2022
Q1
$3.03M Buy
48,430
+2,027
+4% +$109K 0.1% 255
2021
Q4
$2.6M Sell
46,403
-827
-2% -$50.5K 0.08% 278
2021
Q3
$3.07M Sell
47,230
-14,247
-23% -$972K 0.1% 249
2021
Q2
$3.9M Buy
61,477
+27,660
+82% +$1.63M 0.11% 234
2021
Q1
$2.02M Buy
+33,817
New +$1.84M 0.06% 283

Other funds holding AXNX

Chartwell Investment Partners's AXNX Position: Q2 2023 in Review

Chartwell Investment Partners sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2023, closing a stake of 21,377 shares — an estimated $1.17M sold.

Chartwell Investment Partners first reported a position in AXNX in Q1 2021 and held it in 9 quarters. The position peaked at $3.9M in Q2 2021. 234 funds tracked by Wall St. Rank hold AXNX as of Q2 2023.

  • Chartwell Investment Partners reported no remaining Axonics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Chartwell Investment Partners sold 21,377 Axonics, Inc. Common Stock shares in Q2 2023, an estimated $1.17M.
  • Chartwell Investment Partners first reported a position in Axonics, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
  • Chartwell Investment Partners's Axonics, Inc. Common Stock position peaked at $3.9M in Q2 2021.
  • 234 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2023.

Based on Chartwell Investment Partners's 13F filing for Q2 2023, filed 25 Jul 2023.